If untreated, keratoconus may result in significant vision loss and can lead to a corneal transplant in severe cases. However, there are various FDA-approved treatment options available that work to treat the symptoms caused by the thinning and bulging of the cornea.
A corneal transplant may be the only option when the cornea becomes dangerously thin or when sufficient vision can no longer be achieved by contact lenses due to corneal steepening, scarring, or lens intolerance. We’ve compiled some information for you, including an overview of the connection between keratoconus and corneal donations, organ donations, organizations you should be aware of, and how to become a donor. Keep reading to learn more.
Whether you were recently diagnosed with keratoconus, or have been living with it for years, you may be wondering more about this lesser-known – and often misdiagnosed – eye condition. If you’re not familiar, keratoconus, often referred to as KC, is an eye condition in which the cornea weakens and thins over time, causing the development of a cone-like bulge and optical irregularity of the cornea. The condition may result in significant vision loss and can require a corneal transplant in severe cases.
Headaches and light sensitivity are two common conditions that you most likely have heard of before or experienced firsthand. Although there are some easy fixes for these uncomfortable and sometimes inconvenient conditions, it can be stressful if they continue to occur without a known or obvious explanation. While these two bothersome ailments can be caused by a number of different factors, they may be the result of an underlying vision issue, such as keratoconus.
For people diagnosed with progressive keratoconus, it’s likely that iLink FDA-approved cross-linking will be recommended to halt or slow the progression of the condition. Whether your cross-linking procedure is scheduled or you’ve been considering it for a while now, you may be interested in learning more about this minimally invasive procedure.
iLink FDA-approved cross-linking is the only treatment option proven safe and effective in slowing or halting the progression of keratoconus to help preserve patients’ vision.
In June 2019, fourteen years after receiving Lasik to fix her vision, Trayci, 51, noticed her eyesight was declining again. Soon after, she was diagnosed with progressive keratoconus, a rare eye disease in which the cornea weakens and thins over time, causing a cone-like bulge and optical irregularity.
In the first grade, my son Luke began complaining of vision issues, such as blurriness and double vision. To help correct this, we brought him to an optometrist who prescribed him glasses to help him see. However, over the next five to six years, Luke’s vision continued to decline. What my wife and I didn’t realize was that our son was living with a progressive eye disease known as keratoconus.
If you have just recently been diagnosed with keratoconus, or have been living with it for some time, you may be wondering how or when to share your diagnosis with loved ones. It may seem nerve-wracking to open up to family, friends, or even on social media, but sharing your diagnosis is an important step towards accepting your condition and receiving support from others.
It is estimated that an astounding 45 million people in the United States (or about 14% of the population) wear contact lenses. However, the vast majority of users don’t use their lenses properly. The outcomes can be harmful to both your lenses and your overall eye health, potentially leading to a serious eye infection, among other risks.
